Two Centers of excellence will be established in the region, as US-based Bioheart has planed, in order to provide its cell therapy procedures to patients with congestive heart failure (CHF) and peripheral arterial disease (PAD).
Dr Karl Groth, chairman and CEO, Bioheart, said ‘We feel that the Middle East region is a splendid second site for [...]
Recently, Banaja Pharmaceuticals, a Banaja company, has signed an agreement with Qatar Infusions Factory (Qatar Pharma). As agreed Banaja will distribute Qatar Pharma’s products in the Kingdom of Saudi Arabia (KSA), marking the first healthcare cooperation move between KSA and Qatar. The agreement is expected to generate SR 100 million in KSA sales during the [...]